Title : Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphoma.

Pub. Date : 2004 Feb

PMID : 15045033






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This article will review the clinical development of ibritumomab tiuxetan, a yttrium-90-conjugated monoclonal antibody to CD20, for patients with relapsed B-cell non-Hodgkin"s lymphomas. ibritumomab tiuxetan keratin 20 Homo sapiens
2 Ibritumomab is the murine parent anti-CD20 antibody that was engineered to make the human chimeric antibody rituximab. ibritumomab tiuxetan keratin 20 Homo sapiens